International randomised controlled trial of chemotherapy for treatment of Recurrent and Primary Refractory Ewing Sarcoma
Age: 4-50
Phase: 2
If you have Ewing sarcoma which cannot be removed by surgery or has returned after initial treatment, you may be given chemotherapy. This study compares four different chemotherapy treatments:
topotecan and cyclophosphamide (TC)
irinotecan and temozolomide (IT)
gemcitabine and docetaxel (GD)
high-dose ifosfamide (IFOS)
More information can be found at cancerresearchuk.org
To find out more about this trial and whether you could take part, talk to your clinical team.
Locations:
London
- Royal Marsden Hospital
- University College London Hospital
- Royal Marsden Hospital Sutton
North West
- Alder Hey Children’s Hospital, Liverpool
- Clatterbridge Cancer Centre, Wirral
- Christie Hospital, Manchester
- Royal Manchester Children’s Hospital
North East
- Royal Victoria Infirmary, Newcastle upon Tyne
- Freeman Hospital, Newcastle upon Tyne
South West
- Bristol Royal Hospital for Children
- Bristol Haematology and Oncology Centre
Yorkshire and Humberside
- St James’s University Hospital, Leeds
- Leeds General Infirmary
- Sheffield Children’s Hospital
- Weston Park Hospital, Sheffield
South East
- Churchill Hospital, Oxford
- John Radcliffe Hospital, Oxford
- Southampton General Hospital
West Midlands
- Queen Elizabeth Hospital, Birmingham
- Birmingham Children’s Hospital
East Midlands
- Queen’s Medical Centre, Nottingham
- Nottingham City Hospital
- Leicester Royal Infirmary
East Anglia
- Addenbrooke’s Hospital, Cambridge
Northern Ireland
- Royal Belfast Hospital for Sick Children
Scotland
- Royal Aberdeen Children’s Hospital
- Royal Hospital for Children and Young People, Edinburgh
- Royal Hospital for Children, Glasgow
- Beatson West of Scotland Cancer Centre, Glasgow
